StockData

Lycia Therapeutics, Inc. (LYCA) SEC filings

LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)

Close on Nov 18, 2026Market cap –P/E –Yield –

SEC filings

1 of Lycia Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 26, 2026Oct 26, 2026SEC EDGAR

See a number that looks wrong?